Skip to main content
Log in

ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Fritz C. Eilber MD or Joseph G. Crompton MD, PhD.

Ethics declarations

Disclosure

Dr. Arun Singh Daiichi Sankyo —Consultant (October 2019 to present) Deciphera —Consultant (September 2019 to present) Institutional Support for Clinical Trial Certis Oncology Solutions—Board of Directors, Stock RAIN Therapeutics—Institutional Support for Clinical Trial Ayala Therapeutics—Institutional Support for Clinical Trial Tracon—Institutional Support for Clinical Trial

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eckardt, M.A., Graham, D.S., Klingbeil, K.D. et al. ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30, 3104–3105 (2023). https://doi.org/10.1245/s10434-023-13127-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13127-w

Navigation